(S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate CAS 141109-14-0 Kemurnian >99,0% Gambar Unggulan Pabrik

(S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate CAS 141109-14-0 Kemurnian >99,0% Pabrik

Katrangan singkat:

(S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate

CAS: 141109-14-0

Kemurnian:> 99,0% (ing basis garing)

Penampilan: Bubuk Kristal Putih utawa Off-White

Kualitas Tinggi, Produksi Komersial

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate (CAS: 141109-14-0) with high quality, commercial production. We can provide Certificate of Analysis (COA), worldwide delivery, small and bulk quantities available, strong after-sale service. Please contact: alvin@ruifuchem.com

Sifat Kimia:

Jeneng Kimia	(S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate
sinonim	(S)-Metil 2-Amino-2-(2-Klorofenil)asetat Garam Tartaric
Nomer CAS	141109-14-0
Nomer CAT	RF-CC334
Status Simpenan	Ing Simpenan, Skala Produksi Nganti Ton
Formula Molekul	C9H10ClNO2
Bobot Molekul	199.63
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk Kristal Putih utawa Off-White
Kemurnian / Metode Analisis	> 99,0% (ing basis garing)
Rotasi Spesifik [α]20/D	+85,0°～+90,0°
Mundhut ing Pangatusan	<0,50%
Logam abot	<20 ppm
kajelasan	Kualifikasi
Test Standar	Standar Perusahaan
Panggunaan	Perantara Farmasi

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan

Kaluwihan:

FAQ:

Aplikasi:

(S)-(+)-2-Chlorophenylglycine Methyl Ester Tartrate (CAS: 141109-14-0) digunakake minangka perantara ing sintesis organik.Iku uga penengah utawa impurity saka Clopidogrel (CAS: 113665-84-2).Clopidogrel diluncurake ing AS minangka inhibitor agregasi trombosit sing kuat kanggo nyegah kedadeyan iskemik sekunder, kalebu MI, stroke lan kematian vaskular.